参考文献/References:
[1] Bar-shalom R, Valdivia AY, Blaufox MD.PET imaging in oncology[J].Semin Nucl Med, 2000, 30(3):150-185.
[2] Liu RS.Clinical application of [C-11] acetate in oncology[J].Clin Positron Imaging, 2000, 3(4):185.
[3] Lapela M, Leskinen-Kallio S, Varpula M, et al.Metabolic imaging of ovarian tumors with carbon-11-methionme:a PET study[J].J Nucl Med, 1995, 36(12):2196-2200.
[4] Clavo AC, Brown RS, Wahl RL.Fluorodeoxyglucosc uptakc in human cancer cell lines is increased by hypoxia[J].J Nucl Med, 1995, 36(9):1625-1632.
[5] Torizuka T, Clavo AC, Wahl Rl.Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine[J].J Nucl Med, 1997.38(3):382-386.
[6] Hubner KF, McDonald TW, Niethammer JG, et al.Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-18F-deoxyglucose (2-18F-FDG)[J].Gynecol Oncol, 1993, 51(2):197-204.
[7] Yuan CC, Liu RS, Wang PH, et al.Whole-bod PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma.Initial report[J].J Reprod Med, 1999, 44(9):775-778.
[8] Delaloye AB.Radioimmunoimaging and radioim-munotherapy:with these be routin procedures?[J].Semin Nucl Med, 2000, 30(3):186-194.
[9] Kubik-Huch RA, Dorffler W, von Schulthess GK, et al.Value of (18F)-FDG positron emission tomography, computed tomography and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma[J].Eur Radiol, 2000, 10(5):761-767.
[10] Fenchel S, Kotzerke J, Stohr I, et al.Preoperative assessment of asymptomatic adnexal tumors bypositron emission tomography and F-18-fluo-rodeoxyglucosc[J].Nuklearmedizin, 1999, 38(4):101-107.
[11] Zimny M, Schroder W, Wolters S, et al.18F-fluo-rodeoxyglucose PET in ovarian carcinoma:methodology and preliminary results[J].Nuklearmedizin, 1997, 36(7):228-233.
[12] Romer W, Avril N, Oose J, et al.Metabolic characterization of ovarian tumors with positron-emission to-mography and F-18 fluorodeoxyglucose[J].Rofo Fortschr Geb Rontgenstr Neuen Bildgeb V erfahr, 1997, 166(1):62-68.
[13] Schroder W, Zimny M, Rudlowski C, et al.The role of 18F-fluoro-deoxyglucose positron emission tomog-raphy (18F-FDG PET) in diagnosis of ovarian cancer[J].Int J Gynecol Cancer, 1999, 9(2):117-122.
[14] Grab D, Flock F, Stohr I, et al.Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography[J].Gynecol Oncol, 2000, 77(3):454-459.
相似文献/References:
[1]孙昱,符达,刘兴党.卵巢癌循环肿瘤细胞的生物学特性及其临床应用进展[J].国际放射医学核医学杂志,2016,40(1):60.[doi:10.3760/cma.j.issn.1673-4114.2016.01.012]
Sun Yu,Fu Da,Liu Xingdang.Progress in biological characteristics and clinical application of circulating tumor cells in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):60.[doi:10.3760/cma.j.issn.1673-4114.2016.01.012]
[2]王立凯,黄丽娟,潘学继,等.人附睾蛋白4单克隆抗体与免放试剂盒的制备及其对卵巢癌诊断的临床价值探讨[J].国际放射医学核医学杂志,2016,40(3):183.[doi:10.3760/cma.j.issn.1673-4114.2016.03.005]
Wang Likai,Huang Lijuan,Pan Xueji,et al.Preparation of monoclonal antibodies and immunoradiometric assay kit against human epididymis protein 4 and its clinical value in diagnosis of ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):183.[doi:10.3760/cma.j.issn.1673-4114.2016.03.005]
[3]宋梦姣,韩栋梁,葛宁,等.放疗增敏研究中人卵巢癌SKOV3乏氧细胞模型的建立方法[J].国际放射医学核医学杂志,2014,38(6):356.[doi:10.3760/cma.j.issn.1673-4114.2014.06.002]
Song Meng-jiao,Han Dong-liang,Ge Ning,et al.The method of establishing the hypoxic SKOV3 cellular model in the research of radiotherapy sensitizer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):356.[doi:10.3760/cma.j.issn.1673-4114.2014.06.002]
[4]李鹏,赵卫威,杨建伟.18F-FDG PET-CT在探测卵巢癌术后复发与转移中的应用价值[J].国际放射医学核医学杂志,2012,36(6):348.[doi:10.3760/cma.j.issn.1673-4114.2012.06.007]
LI Peng,ZHAO Wei-wei,YANG Jian-wei.18F-FDG PET-CT imaging in the detection of recurrent and metastasis ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):348.[doi:10.3760/cma.j.issn.1673-4114.2012.06.007]
[5]薛艳,安瑞芳.放射免疫显像在妇科肿瘤中的研究与应用[J].国际放射医学核医学杂志,2006,30(1):36.
XUE Yan,AN Rui-fang.A research on radioimmunoimaging and its application in diagnosis of gynecological tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):36.
[6]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):10.
[7]陈香,赵军.PET-CT在非小细胞肺癌中的应用[J].国际放射医学核医学杂志,2005,29(3):97.
CHEN Xiang,ZHAO Jun.The application value of PET-CT imaging in non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):97.
[8]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):197.
[9]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):201.
[10]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):205.